Overview of evidence prior to rollout
HART have been asked to submit evidence to module 3 of the Covid-19 Public Inquiry. That module is about the impacts on healthcare but we were specifically asked to include evidence around deaths in males aged 15-18 years of age and so provided an overview of the full impact these novel products have had on the healthcare system. What follows are some of the highlights. There will be three parts to this series. Here the evidence on what was known before rollout will be presented. Part two covers the evidence after rollout (excluding deaths) and part three the evidence on deaths.
It is worth remembering how cautious people were about any novel products that might claim to prevent covid. In February 2020, Chris Whitty said,
“The rate limiting steps are late clinical trials for safety & efficacy, & then manufacturing. For a disease with a low (for the sake of argument 1%) mortality a vaccine has to be very safe so the safety studies can’t be shortcut. So important for the long run.”
He was right.
The belief that vaccines were safe had led to a circular belief that vaccines required fewer safety checks than other novel therapies. Novel vaccines take a decade or more to go through safety checks. Flu vaccines don’t. These novel drugs were treated like flu vaccines for regulatory purposes.
The regulators failed us in numerous ways as set out in The Perseus Report. Examples include:
- Companies were allowed to skip testing for gene and cancer toxicity and even studies showing how much spike is produced, for how long and where in the body it reaches. Pfizer said these studies were “not considered necessary.” Even while their trial info sheet said “Due to the urgent need for a vaccine against Covid-19, with agreement from the MHRA, some of the tests usually required for a newly manufactured vaccine.have been modified, in order to make the vaccine available more quickly for assessment.”
- They did not demand these studies were done after rushed emergency approvals either. No human studies were carried out to see what happened to the synthetic modified RNA – no-one knows how long it takes to be removed from the body. There is evidence that in some it lasts between at least 28 days and 4 months in the blood.
- The regulators let the pharma companies get away with terminating the placebo arm of the study after ~3months by offering them all the novel products.This was despite us knowing that narcolepsy caused by Pandemrix vaccine took on average of 8 months to be diagnosed.
- The lipid nanoparticles that deliver the modified synthetic mRNA are themselves toxic. This mechanism of delivery was shelved in 2016 for gene therapy to treat inherited genetic conditions because of the multiple doses needed. It was claimed it could still be used in vaccine technology because that only requires one dose…
- The viral vector used for delivering the AstraZeneca DNA message was reported in 2007 to cause platelet activation, which can lead to blood clots.
- There were many more points made including failings in investigating deaths, failing to listen to patients, problems with manufacturing processes and problems with accountability and governance all of which are in the report.
Since 2005 there have been concerns about the regulator losing “sight of the need to protect and promote public health.” The CEO of the MHRA, Dame June Raine, claims the MHRA is now an “enabler” not a “watchdog.” Even before there was political capture there were pre-existing conflicts of interest.
The spike protein is the most toxic part of the virus. It damages lungs, vessel walls and causes clots. Part of the sequence is identical to a region of a bacterial sequence that can bind directly to a particular type of white blood cells resulting in lethal cytokine storms. This part of the sequence was heavily mutated in the Omicron variant making it less lethal. However, even the most recent injections contained the original Chinese spike sequence with this dangerous sequence.
The manufacturers decided to use the WHOLE chinese spike sequence rather than parts of it, or peptides, which have been shown to be safer for vaccine design. Some manufacturers modified the spike so that it could not bind to the receptor and enter a cell. This might have reduced some harm from receptor binding but not from the action of spike within cells. The spike was delivered into cells so spike was produced INSIDE the cells in the first place. AstraZeneca did not modify the sequence. From November 2020 it was clear that parts of AZ spike could be shed outside of cells.
The Pfizer and Moderna clinical trial data shows a higher rate of serious adverse reactions from the treatment group (12.5 per 10,000) than any reduction in serious events from covid (2.3 and 6.4 per 10,000 for Pfizer and Moderna respectively). Yet the claim of 90%+ efficacy was all that was reported and all that Dame June Raine claimed she needed to see in order to approve the drugs.
AZ issued a press release claiming 100% efficacy against hospitalisation and death after only two severe covid hospitalisations and one death in the placebo arm. This claim was repeated widely and was believed.
At the time, the priority was to protect the old and vulnerable who accounted for 98% of covid deaths. There were going to be 15 million jabs to freedom:
The evidence presented is damning. The failures of the regulators to adequately test the safety and efficacy of these novel vaccines are shocking. The circular belief that vaccines required fewer safety checks than other novel therapies is a dangerous assumption that has put the lives of millions at risk. The fact that serious adverse reactions were higher in the treatment group than any reduction in serious events from covid is deeply concerning. We must demand accountability from the regulators and demand that the safety and wellbeing of the public is always the top priority, not profit or political gain. There was total regulatory failure in allowing these products to be given to anyone, which was compounded by not withdrawing them promptly once evidence these issues were clinically relevant became clear.
